What is the dosage of ?

is available in 5 dosages, including mixed Pack, mixed Pack, mixed Pack, mixed Pack and mixed Pack

treats Extravasation of Diagnostic and Therapeutic Materials and Immunologic Deficiency Syndromes

contains hyaluronidase and immunoglobulin G which is a Endoglycosidase

What is mechanism of action?

mechanism of action is Antigen Neutralization

HyQvia Prescribing & Dosing Schedule

Dosage & Administration

For subcutaneous use only

The recommended rHuPH20 dose is 80 U/g Immune globulin G (IgG), which corresponds to 0.5 mL rHuPH20 solution per 10 mL Immune Globulin Infusion 10% (Human) solution for both indications.

PI

Initiation of Treatment with HYQVIA

* Administer the first dose approximately one week after the last infusion of their previous treatment.
* Increase the dose and frequency from a 1-week dose to a 3-or 4-week dose.

Switching from Immune Globulin Intravenous (Human) [IGIV] treatment:

* Use same dose and frequency as previous intravenous treatment after the initial ramp-up.

Naïve to Immune Globulin Subcutaneous (Human) [IGSC] treatment or switching from IGSC treatment:

* 300 to 600 mg/kg at 3 to 4-week intervals, after initial ramp-up.

CIDP

Switching from Immune Globulin Intravenous (Human) [IGIV] treatment:

* Patient must be on stable doses of IGIV.
* The starting dose and dosing frequency of HYQVIA is the same as the patient’s previous IGIV treatment. The typical dosing interval range in the clinical trial for HYQVIA was 2 to 4 weeks.

Get Your Patient on HyQvia

See your patient's specific prior authorization requirements including coverage restrictions and step therapies

Or select your Insurance from the list below:

HyQvia Prescribing Information

Contact Medical Science Liaison

Report Adverse Event

HyQvia Prior Authorization Resources

Most recent state uniform prior authorization forms

Verified: Sep 24, 2024Arizona - Uniform Prior Authorization Form

Verified: Sep 24, 2024Colorado - Uniform Prior Authorization Form

Verified: Sep 24, 2024Hawaii - Uniform Prior Authorization Form

Verified: Sep 24, 2024Illinois - Uniform Prior Authorization Form

Verified: Sep 24, 2024Indiana - Uniform Prior Authorization Form

Verified: Sep 24, 2024Louisiana - Uniform Prior Authorization Form

Verified: Sep 24, 2024Minnesota - Uniform Prior Authorization Form

Verified: Sep 24, 2024New Hampshire - Uniform Prior Authorization Form

Verified: Sep 24, 2024New Mexico - Uniform Prior Authorization Form

Verified: Sep 24, 2024Oregon - Uniform Prior Authorization Form

Verified: Sep 24, 2024Texas - Uniform Prior Authorization Form

Verified: Oct 05, 2024Washington - Uniform Prior Authorization Form

Verified: Oct 05, 2024Wisconsin - Uniform Prior Authorization Form

Benefits investigation

Hyqvia One Path Start Form

HyQvia Preferred Pharmacy

Pharmacy List

HyQvia Financial Assistance Options

Copay savings program

Hyqvia One Path Start Form

Enroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form